CCIG
Computational Clinical Imaging Group — Turning medical images into clinical decisions

Computational Clinical Imaging Group

Champalimaud Foundation

Turning medical images into clinical decisions

One continuous pipeline — from clinical questions to validated tools running beside clinicians. We combine clinical research across six cancer sites with machine-learning development, rigorous validation, software platforms, education, and international collaboration.

01

Clinical Research

Radiomics and deep learning across six cancer types, grounded in reproducibility and external validation.

02

Software Platforms & Tools

Platforms such as Clinity and agentic systems like ARIA that bring validated methods into clinical workflows.

03

Training ML Models

Developing radiomics, deep learning, and self-supervised models from large heterogeneous clinical imaging datasets.

04

Validating ML Models

External validation, robustness testing, and quality frameworks so models survive real clinical practice.

05

International Collaborations

Anchored in EU consortia and an international clinical network across radiology, pathology, and urology centres.

06

Education & Clinical Services

Training researchers and clinicians, hosting visiting students, and supporting clinical imaging services.

Scientific impact

A track record in clinical radiomics, field leadership on trustworthy AI standards, and European collaborative programmes.

195+

Publications

7,966

Citations

45

h-index

€3.7M

External funding

Clinical research

Radiomics and deep learning across six cancer types, grounded in reproducibility and external validation.

Brain

Predicting molecular subtype and prognosis from MRI — including IDH status and survival signatures with external validation.

Breast

Automated lesion segmentation and radiomics to predict pathologic complete response to neoadjuvant therapy.

Lung

CNN-based detection and delineation of pulmonary lesions on CT for volumetric quantification.

Multiple Myeloma

Quantitative bone-marrow MRI and fat-fraction dynamics for early treatment-response assessment.

Rectum

Diffusion and perfusion MRI biomarkers supporting staging, response assessment, and clinical imaging research.

Prostate

Flagship programme on ProstateNET — segmentation, detection, characterisation, and fewer unnecessary biopsies from bpMRI.

CCIG clinical research portfolio following the patient cancer journey

Research focus

From radiomics and self-supervised learning toward agentic AI that supports clinical decisions.

Radiomics & Deep Learning

Imaging biomarkers and deep models across six cancer sites, with emphasis on reproducibility, robustness, and cross-scanner generalizability.

Self-supervised & Foundation Models

Learning robust representations from large unlabeled clinical archives, then adapting them efficiently to new tasks and sites.

Agentic Clinical AI

Moving from predictions to explainable decisions — multi-agent systems that retrieve, reason, and recommend with clinician oversight.

CCIG mandate — clinical research, software platforms, training and validating models, collaborations, and education

People

Researchers and collaborators at CCIG.

View all →
Nickolas Papanikolaou

Nickolas Papanikolaou

Group Lead · Principal Investigator

Principal Investigator

Leads CCIG at Champalimaud Foundation. Research spans radiomics, trustworthy clinical AI, and agentic systems that turn imaging predictions into explainable decisions. PI of H2020 ProCAncer-I; contributor to FUTURE-AI, CLAIM, and EuSoMII METRICS standards.

José Almeida

José Almeida

Postdoctoral Researcher

Postdoctoral Researcher

Develops deep learning and self-supervised methods for clinical imaging, including prostate MRI characterisation and foundation-model approaches for radiology.

Alexandre Calado

Alexandre Calado

Postdoctoral Researcher

Postdoctoral Researcher

Works on clinical imaging AI models and translational pipelines that support diagnosis and decision-making across CCIG cancer programmes.

Projects

Active and completed research initiatives at CCIG.

View all →

AI-BRIDGE

Active

AI for Public Good in Health — fine-tuning cancer imaging AI for new settings without moving sensitive data (€2M).

AI for Public Goodcancer imagingbreast cancerprostate cancerEuropean Commission

EUCAIM

Active

European Federation for Cancer Images — federated cancer imaging infrastructure.

cancer imagingfederationinfrastructure

ReSTAGE

Active

European consortium advancing imaging and data-driven methods for oncology care.

rectal canceroncologyimaging
Visit project website →

BINDER

Completed

National grant advancing bio-inspired deep learning methods for radiomics.

radiomicsdeep learningnational grant

ProCAncer-I

Completed

AI platform for prostate cancer MRI — diagnosis, metastases detection, and treatment response (€1.25M).

prostate cancerAIMRIH2020ProstateNET
Visit project website →

BOUNCE

Completed

Modelling resilience in breast cancer recovery across clinical, lifestyle, and psychosocial dimensions (€0.5M).

breast cancerresilienceclinical studyH2020
Visit project website →

Recent publications

Selected papers from the group.

View all →

Agentic AI for prostate cancer: a vision for multimodal clinical intelligence

2026

N Papanikolaou, AR Padhani, F Sanguedolce

European Urology Oncology 9 (4), 1005-1007

Artificial Intelligence for Prostate Cancer Detection and Screening on MRI in Global Populations: The SCARLET-1 Study

2026

A Saha, JS Bosma, JJ Twilt, ABCD Ng, A Asif, K Magudia, PEZ Larson

Radiology 321 (1), e262081